# ADMA Biologics, Inc (NASDAQ: ADMA), Boca Raton, FL – FDA Inspections

Source: https://www.keypedia.com/companies/adma-biologics-inc/dcb996fb-4a71-44fe-87f1-cfe3979d4182

> Inspection records and compliance data for ADMA Biologics, Inc in Boca Raton, Florida. 8 FDA inspections on record (2 OAI), 2 Form 483s, last inspected December 11, 2024. Publicly traded as NASDAQ: ADMA.

---

## Details

- Name: ADMA Biologics, Inc
- FEI Number: 1000525461
- Facility Type: Manufacturer
- Address Line 1: 5800 Pk Commrce Blvd
- City: Boca Raton
- State: Florida
- Zip Code: 33487
- Country Name: United States
- Address: 5800 Pk Commrce Blvd, Boca Raton, Florida 33487, United States
- Country: United States

## Stock

- Stock ticker: ADMA
- Exchange: NASDAQ
- Share price: $13.24
- Market cap: $2.9B
- Price as of: November 13, 2026

## Related Documents

- [483 - ADMA Biologics, Inc - Unknown Date](https://www.keypedia.com/records/483/adma-biologics-inc/84bd853c-69ff-4bd8-897d-4d6b754398e0) — source: FDA, date: Invalid Date
- [483 - ADMA Biologics, Inc - Unknown Date](https://www.keypedia.com/records/483/adma-biologics-inc/f94a295e-b77d-4b72-959a-36c3f32fd427) — source: FDA, date: Invalid Date
- [483 - ADMA Biologics, Inc - 2024-12-11](https://www.keypedia.com/records/483/adma-biologics-inc/d5a0d911-2d27-49c0-8335-a6f11c190d27) — source: FDA, date: December 11, 2024
- [FDA Inspection 1256275 - ADMA Biologics, Inc - 2024-12-11](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/81f31913-5145-4320-88eb-71fd5f3425fc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 11, 2024
- [FDA Inspection 1219342 - ADMA Biologics, Inc - 2023-09-20](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/31541623-72bc-4c97-a8d8-f7d393a56f6c) — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2023
- [EIR - ADMA Biologics, Inc - 2021-08-12](https://www.keypedia.com/records/eir/adma-biologics-inc/0a56dd9b-8cfd-4d25-85ef-a7ff2efbe6e9) — source: FDA, date: August 12, 2021
- FDA Inspection 1150114 - ADMA Biologics, Inc - 2021-08-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2021
- FDA Inspection 1150114 - ADMA Biologics, Inc - 2021-08-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2021
- [483 - ADMA Biologics, Inc - 2021-08-03](https://www.keypedia.com/records/483/adma-biologics-inc/8b5aec1c-3424-460c-8d86-398a3e0fbce4) — source: FDA, date: August 3, 2021
- [483 - ADMA Biologics, Inc - 2018-04-12](https://www.keypedia.com/records/483/adma-biologics-inc/7e6697ae-e4d9-46bc-85b0-816179d3ad68) — source: FDA, date: April 12, 2018
- [FDA Inspection 1049629 - ADMA Biologics, Inc - 2018-04-12](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/b5405d37-cfbd-4a12-aea8-1f51ffeecff0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 12, 2018
- [FDA Inspection 974061 - ADMA Biologics, Inc - 2016-03-03](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/7cfce6d2-440b-4b1c-a3d4-96c2235b0b79) — classification: Official Action Indicated (OAI), source: FDA, date: March 3, 2016
- [FDA Inspection 892829 - ADMA Biologics, Inc - 2014-08-14](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/dbba3019-a5fa-4567-9f08-bebe755c3f5c) — classification: Official Action Indicated (OAI), source: FDA, date: August 14, 2014
- FDA Inspection 783712 - ADMA Biologics, Inc - 2012-05-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2012
- FDA Inspection 698054 - ADMA Biologics, Inc - 2010-11-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 10, 2010

## Related Companies

- [GenIbet Biopharmaceuticals, S.A.](https://www.keypedia.com/companies/genibet-biopharmaceuticals-sa/0caa1843-f97a-4138-b02a-16af961df290)
- [Kedrion Biopharma Inc.](https://www.keypedia.com/companies/kedrion-biopharma-inc/e6cf606f-c996-4278-ad90-ec69fbd2a7f7)
- [The Abraham J. And Phyllis Katz Cord Blood](https://www.keypedia.com/companies/the-abraham-j-and-phyllis-katz-cord-blood/2665cdeb-06d3-4c71-8c69-e14cc4c81536)
- [Instituto Bioclon, S.A. de C.V.](https://www.keypedia.com/companies/instituto-bioclon-sa-de-cv/54617f01-2e0a-42fc-9ffb-5f7925f8b7aa)
- [CSL Behring GmbH](https://www.keypedia.com/companies/csl-behring-gmbh/21a38e53-2e5d-4c9e-a287-79597f091cc6)
- [Octapharma Produktionsgesellschaft Deutschland mbH](https://www.keypedia.com/companies/octapharma-produktionsgesellschaft-deutschland-mbh/6a1a14b1-f958-4ba6-b283-5c92ef67a783)
- [Adimmune Corporation](https://www.keypedia.com/companies/adimmune-corporation/ef2a0feb-a3b7-45e4-91a6-15d344543027)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/851434de-295b-430d-b638-f2e9f50b0531)
- [CSL Behring L.L.C.](https://www.keypedia.com/companies/csl-behring-llc/bb057a50-8ebe-4207-b535-b5ecc4b342d9)
- [Grifols Therapeutics LLC](https://www.keypedia.com/companies/grifols-therapeutics-llc/2e4dd489-4e70-4ef7-a1f8-f0267f91fab5)

## Related Officers

- [Michael C. Kennedy](https://www.keypedia.com/people/michael-c-kennedy/3bff77b0-1901-4294-badc-754a94983a13)
- [Cynthia Jim](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Michele L. Forster](https://www.keypedia.com/people/michele-l-forster/5e4b6db7-412f-4e4f-87a9-8af15a16429f)
- [COO / Vice President](https://www.keypedia.com/people/michael-l-forster/93e914d1-417a-4520-85b7-7c43aba43c92)
